Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment

Histone deacetylase (HDAC) is one of the most characterized epigenetic modifiers, modulating chromatin structure and gene expression, which plays an important role in cell cycle, differentiation and apoptosis. Dysregulation of HDAC promotes cancer progression, thus inhibitors targeting HDACs have ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yichen, Hong, Jing Han, Ning, Zhiqiang, Pan, Desi, Fu, Xin, Lu, Xianping, Tan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481063/
https://www.ncbi.nlm.nih.gov/pubmed/36120308
http://dx.doi.org/10.3389/fphar.2022.932914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481063/
https://www.ncbi.nlm.nih.gov/pubmed/36120308
http://dx.doi.org/10.3389/fphar.2022.932914

Ejemplares similares